Spero Therapeutics Inc (SPRO)
Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update
Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update
Immediate Report
Arhaus Announces Participation in Upcoming Investor Conferences
Alpha and Omega Semiconductor Reports Financial Results for Fiscal Fourth Quarter and Fiscal Year Ended June 30, 2026
Grocery Outlet Holding Corp. Announces Second Quarter Fiscal 2026 Financial Results
AEVEX Corp. Announces Financial Results for Second Quarter 2026
REKLAIM ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING
Acquisition of Own Shares
PTC to Expand Rare Disease Portfolio with Acquisition of BLA-Stage ST-920 Fabry Disease Program
WhiteFiber and Krambu Partner to Bring 100MW of High-Density GPU Infrastructure Capacity to Market in 2027